Felix Nitschke Selected Research

Glial Fibrillary Acidic Protein

1/2021

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felix Nitschke Research Topics

Disease

11	Lafora Disease 02/2024 - 05/2013
5	Epilepsy (Aura) 11/2021 - 05/2013
4	Adult Form Polyglucosan Body Disease 02/2024 - 01/2019
3	Neuroinflammatory Diseases 11/2021 - 01/2021
2	Glycogen Storage Disease Type IV (Andersen's Disease) 02/2024 - 01/2022
2	Muscular Diseases (Myopathy) 02/2024 - 01/2022
2	Glycogen Storage Disease (Glycogenosis) 10/2020 - 01/2019
1	Necrosis 02/2024
1	Disease Progression 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019

Drug/Important Bio-Agent (IBA)

11	GlycogenIBA 02/2024 - 05/2013
5	polyglucosanIBA 02/2024 - 08/2017
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2024 - 01/2017
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024 - 01/2017
2	EnzymesIBA 01/2022 - 10/2020
2	Glycogen Synthase (Synthase I)IBA 01/2022 - 01/2021
1	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 02/2024
1	Antisense OligonucleotidesIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	GlucansIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	UbiquitinIBA 01/2017

Therapy/Procedure

1	Therapeutics 11/2021